ID   UOMi009-A
AC   CVCL_C3MJ
SY   ACS-hiPSC-HPP3
DR   BioSamples; SAMEA110654725
DR   hPSCreg; UOMi009-A
DR   Wikidata; Q116050744
RX   PubMed=36152425;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Sequence variation: Mutation; HGNC; 438; ALPL; Simple; p.Glu191Lys (c.571G>A) (E174K); ClinVar=VCV000013670; Zygosity=Heterozygous (PubMed=36152425).
CC   Sequence variation: Mutation; HGNC; 438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Heterozygous (PubMed=36152425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=36152425; DOI=10.1016/j.scr.2022.102921;
RA   Srivastava A., Siwach I., Rockman-Greenberg C., Dhingra S.;
RT   "Reprogramming of hypophosphatasia patient cells to generate a new
RT   human iPSC cell line (UOMi009-A).";
RL   Stem Cell Res. 64:102921-102921(2022).
//